MedTrace Logo

Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases

NCT01584622 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-07-01

No results posted yet for this study

Summary

The purpose of the study is to evaluate the effectiveness of the CADence system, a non-invasive device, in detecting greater than or equal to 50% coronary stenosis anywhere in the coronary tree.

Conditions

Interventions

DEVICE

CADence System

Non-invasive detection of \> or equal to 50% stenosis in any of the major coronary arteries.

Sponsors & Collaborators

  • AUM Cardiovascular, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert Wilson, MD · University of Minnesota

  • Roxana Mehran, MD · Mt. Sinai

  • James Chapman, MD · Cheyenne Vascular & Heart Institute

  • Mark Tannenbaum, PhD · Iowa Heart Center

  • Robert Schwartz, MD · Abbott/Minneapolis Heart Institute

  • Jeff Chambers, MD · Mercy Hospital

  • Giora Weisz, MD · Columbia University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-12-31
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01584622 on ClinicalTrials.gov